Compare VIR & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | HLMN |
|---|---|---|
| Founded | 2016 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2019 | 2020 |
| Metric | VIR | HLMN |
|---|---|---|
| Price | $9.63 | $7.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $19.43 | $11.60 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.49 | ★ 122.22 |
| EPS | N/A | ★ N/A |
| Revenue | $68,556,000.00 | ★ $1,552,224,000.00 |
| Revenue This Year | $270.22 | $7.65 |
| Revenue Next Year | N/A | $4.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.41 |
| 52 Week Low | $4.16 | $6.63 |
| 52 Week High | $11.66 | $10.85 |
| Indicator | VIR | HLMN |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 42.32 |
| Support Level | $8.48 | $6.96 |
| Resistance Level | $10.29 | $8.59 |
| Average True Range (ATR) | 0.42 | 0.28 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 71.95 | 51.27 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.